Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

15 December 2002

Risk Factors of Gingival Overgrowth in Kidney Transplant Recipients Treated with Cyclosporine

M Radwan-Oczko, M Boratyńska, M Klinger, M Ziętek

Ann Transplant 2003; 8(4): 57-62 :: ID: 7568

Abstract

Objectives. Gingival overgrowth is a common side effect of cyclosporine A (CsA) therapy. The pathogenesis of CsA-induced gingival overgrowth
is still debated. The influence of CsA dosage and its trough level, HLA phenotype, gender and the administered calcium channel blocker on
incidence and severity of overgrowth were studied. Moreover, relationship of overgrowth with plasma level of TGF-beta 1 was assessed.
Methods. Degree and extent of gingival overgrowth were tested in 124 kidney transplant recipients treated with CsA, in 9 patients treated with
azathioprine and in 21 patients treated with tacrolimus, and various calcium channel blockers.
Results. Gingival overgrowth was found in 46% of patients treated with CsA. Total yearly CsA dosage was significantly higher in patients with
overgrowth. Gingival overgrowth was observed in: 86% of patients treated with nifedipin, 47% with amlodipin, 35% with verapamil. HLA-DR
antigens analysis showed that half of the patients with DR-2 allele suffered from overgrowth. Gingival overgrowth was found twice as often in males than in females. Plasma level of TGF-beta1 was similar in patients with or without overgrowth. Gingival overgrowth was not found in patients treated with azathioprine or tacrolimus despite that half of the patients received nifedipine or amlodipine.
Conclusions. The study revealed high frequency of overgrowth in renal graft recipients treated with CsA. Overgrowth severity was larger in
patients treated simultaneously with nifedipine or amlodipine. CsA dosage, male sex and HLA-DR2 phenotype were risk factors of gingival
overgrowth. None of the patients treated with tacrolimus suffered from gingival overgrowth.

Keywords: Alleles, Amlodipine - adverse effects, Calcium Channel Blockers - adverse effects, Cyclosporine - adverse effects, Gingival Overgrowth - etiology, Gingival Overgrowth - genetics, Gingival Overgrowth - immunology, HLA-DR2 Antigen - genetics, Immunosuppressive Agents - adverse effects, Kidney Transplantation - adverse effects, Kidney Transplantation - immunology, Nifedipine - adverse effects, Risk Factors, Risk Factors, Sex Factors

Add Comment 0 Comments

In Press

Original article  

Post-Donation Regret and Anxiety Among Family Living Liver Donors: The Mediating Roles of Family Relationsh...

Ann Transplant In Press; DOI: 10.12659/AOT.944176  

Original article  

Effect of the Organ Donation Quality System on Donation Activity of Warsaw Hospitals

Ann Transplant In Press; DOI: 10.12659/AOT.943520  

Original article  

Clonal Hematopoiesis-Associated Gene Mutations Affect Acute Graft-Versus-Host Disease After Hematopoietic S...

Ann Transplant In Press; DOI: 10.12659/AOT.943688  

Original article  

Impact of Recipient and Donor Body Mass Index on Survival Outcomes After Intestinal Transplantation: A Unit...

Ann Transplant In Press; DOI: 10.12659/AOT.943994  

Most Viewed Current Articles

05 Apr 2022 : Original article   12,201

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   8,720

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

12 Jan 2022 : Original article   8,640

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

15 Mar 2022 : Case report   6,496

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358